Tranexamic Acid Granules

(Product under development)
Tranexamic Acid GranulesTranexamic acid (TXA) is an antifibrinolytic drug which is used to control bleeding by preventing clot breakdown (fibrinolysis).

TXA is a synthetic derivative of the amino acid lysine that exerts its antifibrinolytic effect through the reversible blockade of lysine binding sites on plasminogen molecules.

Since its introduction into clinical practice over 40 years ago, TXA has been used for a wide variety of clinical conditions where there is haemorrhage or a risk of haemorrhage in increased fibrinolysis and fibrinogenolysis.

The use of the drug is made more attractive in many patients by its ability to inhibit fibrinolysis while having no apparent effect on blood clotting parameters.

Available Form:
Tranexamic Acid Granules
Tranexamic Acid Pellets

Umang Pharmatech equipments used for production of Tranexamic Acid Granules:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Tranexamic Acid Granules
Systematic (IUPAC) Name
Tranexamic Acid Granules
Identifiers
Tranexamic Acid Granules
Chemical data
trans-4-(aminomethyl)
cyclohexanecarboxylic acid
CAS number : 1197-18-8
ATC code : B02AA02
PubChem : CID 5526
DrugBank : APRD01270
ChemSpider : 10482000
UNII : 6T84R30KC1
KEGG : D01136
ChEBI : CHEBI:48669
ChEMBL : CHEMBL877
Formula : C8H15NO2
Mol. mass : 157.21 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL